3D polyelectrolyte scaffolds to mimic exocrine glands: a step towards a prostate-on-chip platform by Picollet-D’hahan, Nathalie et al.
HAL Id: hal-02094038
https://hal.archives-ouvertes.fr/hal-02094038
Submitted on 9 Apr 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
3D polyelectrolyte scaffolds to mimic exocrine glands: a
step towards a prostate-on-chip platform
Nathalie Picollet-D’hahan, Axel Tollance, Cristina Belda Marin, Lavinia
Liguori, Christophe Marquette, Odile Filhol-Cochet, Isabelle Vilgrain,
Guillaume Laffitte, Florence Rivera, Jean-Pierre Alcaraz, et al.
To cite this version:
Nathalie Picollet-D’hahan, Axel Tollance, Cristina Belda Marin, Lavinia Liguori, Christophe Mar-
quette, et al.. 3D polyelectrolyte scaffolds to mimic exocrine glands: a step towards a prostate-on-
chip platform. The EuroBiotech Journal, Sciendo, 2018, 2 (4), pp.180-195. ￿10.2478/ebtj-2018-0048￿.
￿hal-02094038￿
RESEARCH ARTICLEThe EuroBiotech Journal
180  |  VOLUME 2 ISSUE 4  |  OCTOBER 2018  
Medicine and Biotechnology
Abstract
We report our approach to creating a microfluidic chip (namely UroLOC) that mimics the acinar/tubular structure and the 
luminal microenvironment of exocrine glands. The chip utilises a nanostructured membrane that is designed to provide a 3-di-
mensional supporting scaffold for the growth of exocrine acinus epithelial cells. The nanostructured membrane was produced 
using layer-by-layer assembly of polyelectrolytes, and formed into 3-dimensional hemispherical cavities and “finger-like” 
structures in order to mimic the natural architecture of acini found in exocrine glands. We utilised normal (PNT2)  and can-
cerous (PC3, LNCaP) prostate epithelial cells to demonstrate the proof-of-concept of using MALDI (Matrix Assisted Laser 
Desorption Ionisation) profiling of secretions collected after 48 hours of cell growth, with no concentration or purification 
steps and without any a priori on the knowledge of targeted proteins. This MALDI profiling analysis of the crude supernatants 
from 3 different cell lines (PNT2, PC3 and LNCaP) demonstrated the capacity of the MALDI profiling approach to discrim-
inate between the different secretome signatures. The UroLOC concept and secretome profiling that we describe opens new 
opportunities in terms of liquid-biopsy based diagnosis, particularly for the early stages of carcinogenesis.
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Introduction
Monolayer (in 2D) cultures have been very useful models for gene discovery and early 
work on viral transformation, but such 2D systems do not provide a cell-model that rep-
licates the architecture of exocrine gland tissues (1). Cell models that replicate exocrine 
gland architecture are important tools in the search for drugs to combat disease and can-
cer. For example, cancer of breast tissue is a significant cancer amongst women. Vidi et al 
2013 describe methods for the growth of breast epithelial cells into physiologically rele-
vant 3D cell culture, which demonstrate the important roles that cell polarity, cell shape 
and the development of proper basement membranes play in the physiology of exocrine 
tissues in the breast. Such physiologically relevant 3D cell culture models of breast tissue 
are important tools in the search for therapeutic agents to fight disease and cancer of the 
breast tissue. For men’s health, the exocrine prostate gland tissue is a significant cause for 
cancer and other disease. Prostate epithelial cells grown in micro-spheroid cultures in a 
Microwell-mesh 3D culture system responded appropriately to drugs used to treat pros-
tate cancer (2) The use of organoids, as 3D culture models would provide even closer tis-
sue-like conditions for studying drug reaction (3). Those types of 3D cell-culture systems 
provide information of cell responses that are measurable by imaging or spectroscopic 
techniques. The limitation of those 3D epithelial models for acinar structures is that it 
is not possible to access the luminal secretions to measure physiological responses in 
real-time and to identify new cancer biomarkers.
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The use of microfabricated systems, or indeed novel poly-
mer-based cell scaffolds that are coupled to microfluidics, 
would provide the next step toward exocrine organ-on-chip 
cultures that could provide real-time physiological cell re-
sponses (4). The choice of epithelial cells can assist the step to-
ward such capability of measuring real-time physiological re-
sponses. For example, intestinal CaCo-2 epithelial cells have 
been cultured in a Gut-on-Chip device that included a mi-
crofluidics system to access both sides of the intestinal mono-
layer, which provided measurements of metabolic responses 
from the intestinal cells that were closer to that expected in 
a natural biological tissues (5, 6). That Gut-on-Chip device 
comprises a porous PDMS membrane to provide a permeable 
membrane to allow cell secretions to be collected in the mi-
crofluidic system. Nonetheless, PDMS membranes may have 
intrinsic transport, mechanical and structural properties that 
are different from those of the natural basement membrane 
of the tissue. Other materials were used to mimic finger-like 
villi topography such as biodegradable polymers (such as po-
ly-lactic-glycolic acid and poly-lactic-acid) (7), collagen (see 
references in (8)). While intestine-on-chip devices (9) remain 
to date the closest models for finger-like acinar and tubular 
structure, no exocrine-gland-on a chip devices composed of 
hollow protuberances allowing co-cultures and direct sam-
pling of secretions have been developed.
In this paper we describe our approach to creating a micro-
fluidic chip (namely UroLOC) that mimics the acinar/tubu-
lar structure and the luminal microenvironment of exocrine 
glands. The chip utilises a nanostructured membrane that is 
designed to provide a 3-dimensional supporting scaffold for 
the growth of exocrine acinus epithelial cells. This scaffold is 
a porous biomaterial membrane that comprises multiple 3-di-
mensional and hollow protuberances on which adherent cells 
are grown on either side, with the acinar epithelial cells on the 
inside (luminal side) and stromal cells on the outside (glan-
dular side). The acinar epithelial cells on the inside of the 3D 
protuberances produce small volumes of secretions, which 
are collected (by possibly using microfluidics) for analysis of 
the composition of the secreted fluid. These secretions consist 
of all the molecules that can be secreted in the cell culture 
medium such as peptides, proteins, amino acids, miRNAs, 
DNA, RNA. The analysis profile of these secretions makes it 
possible to obtain the secretome, that is to say the qualitative 
and quantitative profile of the secretory components.
Materials and Methods
Nanostructured membrane to support cell growth
The membrane was formed using a layer-by-layer process that 
utilised the polyelectrolytes poly-sodium 4-styrenesulphonate 
(PSS) and poly-allylamine hydrochloride (PAH) (10). The op-
timisation of this membrane for the UroLOC device proceeded 
using 2 protocols. The first protocol constructed the membrane 
inside 3D hemispherical cavities, with the purpose to grow the 
exocrine epithelial cells on these 3D hemispherical membranes 
and to optimize the analytical method for the small volumes 
of secretions from each 3D hemispherical cavity. The second 
protocol was to construct the membrane on a 3D acinar-mimic 
sacrificial mould so as to create a free-standing porous mem-
brane, with the purpose to mimic the biological acinar archi-
tecture with epithelial cells on the inside of the membrane (lu-
minal side) and stromal cells on the outside (basal side).
(a) First Protocol - Mould design, fabrication and optimisation 
The 3D hemispherical cavities were produced from a master 
mould. Fig. 1 illustrates the steps required for the assembly 
of the master mould. An inket printer was used to spot resin 
drops of about 1 nl onto a resin substrate so as to create an 
array of 200 resin hemispheres of 100 μm diameter. This proce-
dure was optimized to avoid the viscous resistance of the resin 
in the injector. Once the master mould was assembled, it was 
replicated by slowly pouring liquid PDMS onto it (Two-part 
Sylgard silicon 10:1 v/v) at RT and allowing the PDMS to po-
lymerize overnight at 60°C (Fig. 1.A). From that master mould, 
a derived mould was formed for the routine production of the 
3D hemispherical cavities. The derived mould consisted of 200 
PDMS hemispherical multi-wells (100 μm x 50 μm) formed 
across a chip with a surface area of 2 cm2. Characterisation of 
the surface and the hemispheres of the PDMS device was per-
formed by scanning electron microscopy (SEM) (Fig. 1.B) and 
by Z stack and 3D reconstruction on a confocal microscopy 
(LSM 710 confocal scanning laser microscope (Carl Zeiss, Jena, 
Germany) (Fig. 1.D). The Z-stack acquisition was carried out 
using a C-apochromat water-immersion objective (magnifica-
tion 63x, NA 1.2, Carl Zeiss).
The derived mould was used to form 3D hemispherical 
cavities in a PDMS chip. Multi-layered polyelectrolyte films 
were assembled inside these 3D hemispherical cavities by al-
ternate coating of PSS (poly (sodium 4-styrenesulphonate; 
Sigma 243051)) and PAH (poly (allylamine hydrochloride; 
Sigma 283223)) following the LbL (Layer-by-Layer) process 
we have previously described (10, 11) (see also Fig. SI.1). The 
3D hemispherical cavities were coated with 16 polyelectrolyte 
(PE) layers in order to obtain a membrane of around 32 nm 
in thickness that was easily visualised with fluorescein (Fig. 
1.C). For that visualization, the PDMS chip containing the 3D 
hemispherical cavities was incubated for 2 hours at RT in a 
solution of Fluorescein (10 μM in PBS) and washed twice in 
PBS before observation. Fluorescein was excited at 488 nm and 
fluorescence was observed using a 510–560 nm filter. 13 suc-
cessive optical slices were captured along the cell z-axis, with 
a step of about 3.5 μm. For 3D reconstruction, PE-Fluorescein 
was scanned with about 50 slices. Images were processed using 
the ZEN software. A color code was established to indicate the 
depth of the well.
(b) First Protocol - Immunocytochemistry and 3D confocal 
analysis 
RWPE1 and WPE1-int lines were used to validate the structur-
al and functional phenotype of prostatic cells grown on the PE 
films inside the 3D hemispherical cavities. The RWPE1 (ATCC 
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Ref. CRL11609) cell-line was derived from non-neoplastic hu-
man prostate epithelial cells via immortalization with human 
papillomavirus. They were used as model for normal prostate 
epithelial cell behaviour, as characterised by a well-established 
polarised morphology (12) and clear cell-cell junctions when 
grown on a flat or curve surface (13). The WPE1-int cells 
(ATCC ref CRL2888) were derived from the RWPE-1 cell-line 
after two consecutive cycles of single cell cloning and were used 
as luminal prostatic cells that have the property to secrete Pros-
tate Specific Antigen (PSA) while conserving a normal epithe-
lial morphology. 
Cells were cultured on the PE films inside the 3D hemi-
spherical cavities from 5 to 8 day days after seeding. Vincu-
lin was chosen to visualize the cell focal adhesions on the PE 
films inside the 3D hemispherical cavities. Cells were perme-
abilized for 40 seconds with Triton X-100 and fixed with 4% 
(v/v) PFA in PBS for 20 minutes and washed once with PBS. 
To block nonspecific antibody binding, cells were incubated 
with 0.1 BSA and 10% goat serum for 1 hour. Primary antibody 
against vinculin (Sigma Aldrich) was used at 1:700 dilution 
(in PBS+Tween 20 0.05%, and 5% goat serum) and incubated 
1 hour at RT followed by 4 PBS washes (45 minutes in total). 
Cultures were then incubated with anti-mouse Cy5 (Jackson, 
dilution 1/500 in PBS+, Tween 20 0.05%, and 5% goat serum). 
The cells were subsequently washed 4 times for 15 minutes with 
PBS. Nuclei were stained with SYBR green (2μg/ml in PBS). 
Confocal acquisition was achieved by exciting with 2 lasers, 
488 (SYBR green) and 543 (Cyanine 5), which allowed for 3D 
reconstruction of 50 optical slices (1 µm step) which were ac-
quired in the Z-axis from the top of the mould (flat region, red) 
to the bottom of the 3D cavity (blue).
(c) First Protocol - Measurement of the volume of secretions 
The volume of secretions from cells grown on the PE-scaffold 
inside the hemispherical cavities was estimated as followed 
(Fig. SI.2). A volume of 50 μl of bromophenol blue solution 
was deposited with Tween 80 (1/1000) on a PDMS mould (Fig. 
SI.2.A.1). The excess of bromophenol blue was absorbed with 
paper towels and discarded so as to leave all the cavities filled 
with bromophenol blue (Fig. SI.2.A.2). The bromophenol blue 
in the cavities was then transferred to Whatman paper (Fig. 
SI.2.A.3). The Whatman filter paper was placed in an Eppen-
dorf tube (0.5 mL) previously pierced with a needle and then 
placed in a second Eppendorf tube (1.5 mL). Hydration of 
Whatman paper was performed with 350 μl H20 + Tween 80 
(1/1000). Then all the contents of the Whatman paper were 
Figure 1. Mould design and fabrication. A. The Master mould was obtained by dropping a biocompatible resin on a rigid resin 
support. The PDMS final mould is composed by 200 hemi-spherical structures of ~ 100 μm on the base and ~ 50 um in heights. The 
pitch between the hemispherical wells is ~ 400 μm. B. Scanning electron microscopy (SEM) of the surface and the hemispheres. 
C. Confocal microscopy (orthogonal section) of the hemisphere coated with multi PE (15 layers alternating PSS-PAH) incubated 
with fluorescein. The fluorescein labels PE allowing the thin layer visualization. D. Confocal scanning laser microscopy of the hemi-
spheres.
A. B.
C. D.
Master
PDMS
PDMS
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eluted by centrifugation at 13400 rpm for 60 s (Fig. SI.2.A, 
4-6). Adding Tween 80 to the bromophenol blue optimized the 
coating inside the PE film-lined cavities and hence increased 
the transfer efficiency to the absorbant Whatman paper (Fig. 
SI.2.B). The volume of bromophenol blue that was transferred 
to the Whatman paper was quantified on the basis of a colori-
metric standard curve that we had previously established using 
known volumes.
(d) First Protocol - Methodology for the collection of cell secretions 
PDMS moulds were placed in 9 well plates for cell culture. The 
cells were seeded over the PDMS mould at high concentration 
(diluted by one-third from T25 cm2) and culture medium with-
out FCS was placed over the PDMS mould to form a large con-
vex meniscus. 24h later the meniscus had decreased so that the 
culture medium was filling only the hemispherical cavities pres-
ent on the moulds. Cells were then stimulated with dihydrotes-
tosterone (DHT, 100 nM) for 24 hours inside the incubator in 
order to stimulate PSA secretion. Particular attention was paid 
to only adding DHT to the hemispherical cavities of the PDMS 
moulds and not across the entire surface of each mould. For 
each condition, the medium from 3 moulds was pooled into 1 
sample for ELISPOT-based analysis, in each of the 4 following 
conditions: WPE1-int – DHT, WPE1-int +DHT, RPTEC and 
3ng of pure PSA. Volumes of secretions collected from moulds 
were spotted on a 1.5 cm2 nitrocellulose membrane. Each spot 
corresponds to 10 µl of supernatant and all dilutions have been 
made with milli-Q water. ELISPOT analysis was performed as 
described in section 4.
(e) Second Protocol - Development of 3D self-supporting PE 
membrane scaffolds
The concept was based on the modular assembly of 3D print-
ed pieces that provided a system to shape the self-supporting 
“acinar-like” PE scaffolds. The methodology relied on using 
alginate as a sacrificial core for PE coating from a shape of ei-
ther alginate “finger-like” structures (Fig. 2, first approach) or 
alginate “wells” (Fig. 3, second approach). In both cases, 3D 
printed pieces were manufactured by 3D Fab platform (Vil-
leurbanne, France) using an Objet Pro 3D printer. The material 
used was acrylate resin, also known as plexiglass, (generally 
transparent to allow microscopy) which was UV photo cured 
after each layer had been deposited.
For the first approach (Fig. 2), the detail of the individual 
3D pieces are illustrated in Fig. SI.3. To create the “finger-like” 
structure that provided the sacrificial core for the PE mem-
brane, alginate (1.5 %) was flowed through the different UroS-
CAF pieces. Three different pieces were assembled and clamped 
together to form the UroLOC device, with PDMS gaskets used 
to avoid leaks in the system. The free end of the UroFLU piece 
was then fit into a three-way valve and connected to a syringe 
that had previously been filled with alginate (1.5-3%). The flow 
of alginate was achieved by a six-channel pump (SDX Teth-
ered Membranes Pty Ltd), which was under software control 
to achieve flow-rates of µL/min so as to slowly and precisely 
control the formation of the “finger-like” extrusions. Alginate 
polymerization was achieved by adding CaCl2 (100 mM) in the 
upper chamber once alginate had started to be extruded. PE 
coating was done over several substrates to which the general 
layer by layer deposition protocol was adapted (see Fig. SI.1). 
PSS and PAH were always prepared in a 1 mg/mL concentra-
tion solution, dissolved in either CaCl2 (5, 100 or 500 mM), 
NaCl (250 or 500 mM), MgCl2 (500 mM) or KCl (500 mM). 
Then, alginate dissolution was done with EDTA.
In the second approach (Fig. 3), sacrificial alginate moulds 
were created from 3D printed pieces containing pillars (Fig. 
3.A). The feasibility of this approach was tested using a proto-
col inspired from a previously published method (14). Square 
moulds were filled with alginate and covered with a piece of 
Whatman paper soaked with CaCl2 (100 mM). A support con-
taining a chamber was then placed on top of the paper and the 
system was hold together with clamps. The resulting chamber 
was then filled with CaCl2 (100 mM). The system was then in-
cubated for 4h at room temperature to allow alginate gelation. 
That protocol produced “finger-like” alginate structures from 
which a free-floating PE membrane was formed (Fig. SI.4.1). 
To go beyond that feasibility of forming a polyelectrolyte mem-
brane and to better control the attachment of the polyelectro-
lyte membrane to a substrate, new pieces namely UroBOXES 
were designed and manufactured by 3D printing (Fig. 3.B). 
PE coating over the UroBOXES was done by assembling the 
green piece with the black one containing the corresponding 
alginate mould. The “cheddar-like” piece (orange one) was then 
used to keep the green piece in tight contact with the alginate 
mould. The whole system was hold together with clamps. PSS 
and PAH solutions were alternatively added to the free surface 
on the green piece and incubated for 5 minutes (Fig. SI.1). A 
washing step with milliQ water followed by a liquid removal 
from the piece with an absorbent paper was done between each 
layer (see Fig. SI.1). This procedure was repeated until the de-
sired number of layers was obtained. All incubation steps were 
done under gentle agitation on a rocking platform (70 rpm) 
and at room temperature.
Some technical issues were addressed during the assembly 
procedure. First, it was required to have a perfect alignment 
between the wells created on the alginate mould and the holes 
in the second piece. This issue was solved by designing the blue 
and green piece with the pillars/holes respectively in the exact 
same position. Secondly, the addition of liquids to the system 
was necessary for alginate gelation, polyelectrolyte coating 
and cell culture. Alginate needs to be contained in a support 
and a non-leaky connection needs to be created between the 
black and blue piece. Therefore, both pieces contain walls to 
avoid these drawbacks. Finally, the green piece was originally 
created with symmetrical walls on both sides of the horizon-
tal plane. However, this design prevented liquid from entering 
the bottom chamber, and placed the horizontal plane outside 
the normal working distance for microscope objectives. This 
design was not appropriate for cell culture nor for imaging by 
inverted microscopy. For these reasons, a new (grey) piece was 
184  |  VOLUME 2 ISSUE 4  |  OCTOBER 2018    
A. B.
C.
Figure 2. Conceptual view of a device integrating nanostructured free-standing supporting membrane. A. Schematic architec-
ture of finger-like nanostructured scaffolds. The polyelectrolyte membrane (PEM, in red) creates acinar/ductal free standing and 
porous 3D structures that enclose the top of the microfluidic culture chamber to control the microenvironment for the cells. B. 
Close-up of the porous nanostructured membrane. Epithelial cells (EC, in green) are on the inside of the polyelectrolyte membrane. 
Cancerous cells are spiked from the outside of the polyelectrolyte membrane. Arrows indicate the secretions produced by EC. C. 
Schematic process of finger-like PE fabrication with sacrificial core (in purple). 
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created with a castellation shape to enable the passage of liquid 
to the bottom chamber as well as to provide the opportunity to 
remove almost completely one of the walls in the green piece, 
which placed the horizontal plane within the working distance 
of the objectives for inverted microscopy. After several trials 
had been done, an extra set of pieces was designed to evaluate 
different diameter sizes as well as the height of the pillars. This 
set consisted in a blue and green piece containing four different 
conditions (h = 0.4 or 1 mm and Ø = 0.5 or 1 mm) with three 
replicas for each condition.
Cell culture and imunofluorescence
RWPE-1 and WPE1-int were growth in KSFM (Life Technolo-
gies, Carlsbad) supplemented with 5 ng/mL of epidermal growth 
factor (EGF) and 50 mg/mL of bovine pituitary extract (Gibco) 
and 1% Penicillin-Streptomycin (Gibco). Cells were cultured up 
to 70% confluence and seeded in T25 Flasks at a density of 2 
× 104 viable cells/cm2. PNT2 (SV40-immortalized normal adult 
prostate epithelial cells), PC3 and LNCaP (cancerous prostatic 
cell lines) previously described (11) were used for MALDI-based 
analysis of the secretome from normal and cancerous cells. 
Among the cancerous cells, PC3 are androgen receptor-negative 
while LNCaP, as androgen receptor-positive cells, have the prop-
erty to secrete PSA. PNT-2 cells were obtained from ECACC 
(N_95012613) and were routinely cultured in RPMI Glutamax 
culture media supplemented with 10% foetal calf serum and 
1% penicillin/streptomycin. PC3 cells (ATCC, CRL-1435) were 
initiated from a bone metastasis of a grade IV prostatic adeno-
carcinoma from a 62-year-old male Caucasian. PC3 cells were 
routinely cultured in RPMI Glutamax culture media (Invitrogen, 
Ref. 61870-010) supplemented with 10% fœtal calf serum (PAA, 
Ref. A15-101) and 1% penicillin/streptomycin (Invitrogen, Ref. 
15140-122). LNCaP (ATCC #1740) were grown in 2D in 25 cm² 
flasks with 5 mL of RPMI 1640 medium supplemented with 10% 
SVF penicillin-streptomycin. Pre-treated SVF was used (charcoal 
filtered) to remove all residues of hormones. All cell lines were 
grown in an incubator at 37°C, 5% CO2, and 95% humidity. For 
different passages, the cells were washed twice with PBS followed 
by the addition of trypsin–EDTA and incubation for 3–10 min 
depending on the cell line. Trypsinisation was stopped by adding 
6 to 8 ml of 0.1% soybean trypsin inhibitor. Cells counting was 
performed following centrifugation (5 min at 1600 rpm) and af-
ter adding 10 µl Trypan Blue to 10 µl of cell suspension.
In order to investigate the invasiveness processes, LNCaP cells 
were labelled with the Molecular Probes_CellTracker™_Green 
CMFDA (5-chloromethylfluorescein diacetate) (Life Technolo-
gies C7025) (3 µM, for 30 minutes) and then introduced into a 
monolayer of PNT-2 epithelial cells once they reached 90% of 
confluency. For immunostaining assays, cells were then incu-
bated for 20 min at room temperature in PFA 4% in PBS then 
rinsed in PBS for 10 minutes and permeabilized 5 minutes in 
0.5% Triton X100 in PBS. Cultures were finally incubated with 
Phalloidin-Cy3 (1:400) in PBS for 1 hour then washed 3x5 min-
utes and then nuclei were stained with Hoechst (2 µg/ml) for 10 
minutes. Stained cells were imaged by fluorescence microscopy 
using a confocal spinning-disk inverted microscope (Nikon TI-E 
Eclipse) with a 20x air objective equipped with a Yokogawa CSU-
1 Unit for z-stack acquisitions and an Evolve EM-CCD camera. 
Primary Renal Proximal Tubule Epithelial Cells (RPTEC) were 
kindly provided by I. Villegrain (CEA Grenoble) and were used 
as control for ELISPOT assay as non-PSA secreting epithelial 
cells.
Biochemical analysis of secretions 
Biochemical studies were carried out on secreted supernatants 
from cells grown in 2D to validate the use of our cell lines and the 
possibility to detect secreted proteins in the supernatants with-
out having to apply purification or concentration steps. The 2D 
format offers very well controlled culture conditions to evaluate 
the minimum number of cells required to perform a secretom-
ics-based Maldi analysis. Moreover, this number of cells and the 
corresponding volume of secretions need to be compatible with 
further microfluidic integration and sampling. PSA was chosen 
as “housekeeper” protein for the secretome.
A.
B.
Figure 3. Schematic of alginate gelation process over 3D printed moulds. A. sacrificial alginate mould (c) is created over a 3D 
printed piece (a) to obtain a 3D shaped polyelectrolyte membrane (d). B.  List of the 3D printed pieces. The assembly of these pieces 
allow the creation of PE pillar-like structures.
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Western Blot was performed with the same supernatant of 
cell culture used for MALDI analysis. Different quantities of 
supernatant were separated by electrophoresis on a NuPAGE™ 
Novex™ 4-12% Bis-Tris Protein Gel (Life Technologies) in MES 
buffer and then transferred onto a nitrocellulose membrane 
(Sigma-Aldrich). The membranes were blocked in 5% non-fat 
milk in Tris-buffered saline, 0.1% Tween 20 (TBS-T, Sigma) for 
1 hour at room temperature and incubated with primary anti-
bodies diluted at 1:1000 in 5% non-fat milk in TBS-T overnight 
at 4°C. Rabbit polyclonal antibodies directed against PSA (PSA/
KLK3 (D6B1) XP® Rabbit mAb ref 5365, cell signalling tech-
nology) and GAPDH (Santa Cruz Biotechnology) were used. 
Membranes were washed three times for 10 min in TBS-T and 
incubated with secondary horseradish peroxidase-conjugated 
antibodies (anti-rabbit, eBiosciences) at a dilution of 1:10000 
in TBS-T for 50 min. Membranes were washed three times for 
10 min in TBS-T and revealed with ChemiDoc™ MP systems 
(BioRad). Chemiluminescence was analysed using a Chemi-
Doc Touch Imaging System (BioRad).
ELISA tests were performed by using a Human Free PSA 
ELISA Kit from Anogen (EL10050) for the in vitro quantita-
tive determination of free Prostate-Specific Antigen (fPSA) 
concentrations in the supernatant. Washing steps were per-
formed with PBS, Tween 0.05% and milk 5% during 15 min. 
Incubation with IgG anti-PSA-ncam was performed during 30 
min and incubation with a rabbit HRP (1:1000) during 30 min. 
Washing step was done with PBS Tween 0.05% during 15 min, 
twice.
The “Proteome Profiler Human XL Cytokine Array Kit” was 
used with 200 µl of the same supernatants used for biochem-
istry and MALDI analysis and following the supplier protocol 
and revealed with ChemiDoc™ MP systems (BioRad) with an 
exposure time of 150 seconds. For the calculation of the in-
tensity of each of the spots, we used the Fiji software with the 
“Microarray profile” plugin. Each protein was spotted twice on 
the microarray and the histogram corresponds to the mean of 
the integrated density obtained for these two spots to which the 
value of the negative control has been subtracted.
Mass Spectrometry-based analysis of secretions
(a) Sample Preparation for MALDI
LC-MS grade Water, Acetonitrile (99.9%), and trifluoroacetic 
acid (99%) were obtained from Sigma-Aldrich. α-Cyano-4-
hydroxycinnamic acid and calibration standard mix (BTS) 
were purchased from Bruker Daltonics. For each spot, 0.6 
µl of cell supernatant was mixed with 0.6 µl of α-Cyano-
4-hydroxycinnamic acid (10mg/ml in acetonitrile/water/
trifluoroacetic acid 50:49,8:0,2 v/v/v) and deposited onto a 384 
MTP AnchorChip Target (Bruker Daltonics). 
(b) MALDI profiling 
MALDI mass spectrometry profiling was performed on an 
Ultraflex III MALDI-TOF/TOF (Bruker Daltonics) equipped 
with a Smart-beam laser operating at 1000 Hz pulse rate. Ions 
were detected in positive linear mode at +20 kV accelerating 
potential, in the mass range of m/z 1000-20000 with ion 
suppression up to 950 Da. On each sample spots, 5000 spectra 
were summed with automatic spectral quality evaluation.
Statistical analysis of spectral data 
Spectra were preprocessed (tophat baseline removal and 
smoothing) and normalized by total ion current (TIC) in Bruker 
Clinprotool software v3.0. 2D peak distribution and Principal 
Component Analysis (PCA) was performed in Clinprotool. 
Unsupervised hierarchical clustering was performed on 
exported spectra from Clinprotool, using log transformation 
of the intensities and clustering via uncentered correlation 
similarity metric (Gene cluster v3.0). For each condition, 3 
biological replicates were analysed 3 times. 
Results 
Validation of the concept of PE scaffolds for acinar-like 
structures reconstruction 
Cells at day 8 were well-organized at the bottom of the PE scaf-
folds and form a monolayer with intercellular tight junctions re-
vealed by immunofluorescence (Fig. 4). Moreover, a protocol to 
collect secretions from cells grown in the wells was established. 
The volume of secretions was determined to be 1.76 µl per 100 
wells, according to the bromophenol blue volume which has 
been transferred to Whatman paper and then measured from 
the calibration curve (Fig. 4.B). This volume of 1.76 µl per well is 
consistent with a microfluidic handling.
In order to validate the exocrine function of prostatic cells 
grown at the bottom of the wells, we verified that cells did se-
crete PSA. For this, the medium present above 3 moulds was 
harvested in 3 conditions. WPE1-int unstimulated with DHT, 
WPE1-int stimulated with DHT, but also 3 PDMS mould with 
RPTEC cells (renal cells, as negative control). A positive control 
was made with 3 ng of pure PSA (Fig. 4.C). We observed that the 
medium of the stimulated WPE1-int present PSA. The ELISPOT 
analysis confirms that it is possible to detect PSA secreted by cells 
growing in small wells that have an hemisphere-shape that mim-
ics the dimensions of acinar-like structures.
To validate our hypothesis that cancerous cell lines can be 
discriminated on the basis of their secretome, we performed 
biochemical analysis from their supernatant. As expected and 
confirmed with ELISA test, PSA secretions were detected from 
LNCaP, with or without stimulation (15) by contrast to the 
other cell lines that are described as not secreting PSA (16) 
(Fig. SI.5). With the same LNCaP supernatant used for ELISA, 
we performed ELISPOT (Fig. SI.5.B) and Western Blot (Fig. 
SI.5.C) assays as second confirmation. The protease microar-
rays showed overexpression of PSA and many other known 
proteins (e.g. Urokinase, Kallikrein 10, 7, 6, 5, Cathepsin D) in 
the LNCaP cell-line compared to the others (Fig. SI.5.D).
Mass Spectrometry Profiling of the secretome from 
cancerous cells
To avoid any interference of FCS within MALDI analysis, FCS 
was replaced with BSA 2g/L, as previously described in the lit-
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erature (17, 18), during the incubation phase used to recov-
er the secretory fluid. In the final point after five days, a Live/
Dead staining showed no cell mortality and no alteration in 
cell morphology (data not shown). After biochemistry valida-
tions, supernatants from LNCaP, PNT2 and PC3 cell cultured 
as described above were analyzed by MALDI MS in the range 
of 1000 to 20000 Da for peptides/small proteins profiling. The 
amount of supernatant spotted was normalized to approxi-
mately 300 cells per sample.
Fig. 5A shows PCA of the 3 different cell lines. Spectra are 
projected in a coordinate system defined by the PCs (95 % of 
the total variance). The best segregation between normal and 
cancerous cells is reached by representing data in a PC1-PC2 
plane.  The score plots reveal a trend of separation of MALDI 
spectra corresponding to the different cell lines. The discrim-
ination of the supernatants from the different cell types was 
further confirmed by the unsupervised hierarchical clustering 
analysis (Fig. 5.B). The obtained dendrogram indicates that 
MALDI MS data of the supernatants are specific of each cell 
lines. Fig. 5.C shows the two peaks that have the most signifi-
cant p-value to differentiate the 3 cell types (see also Fig. SI.6). 
The 2D peak distribution resulted in a clear segregation of the 
3 cell lines. 
To assess the ability to differentiate a healthy PNT2 culture 
from a PNT2 and LNCaP co-culture, different numbers of 
LNCaP cells (1,000, 10,000 and 50,000) have been seeded in 
a PNT2 culture and MALDI profiling analysis has been per-
formed on the supernatant. We first observed that spiked can-
cerous cells were properly incorporated in the non-cancerous 
cell monolayer (Fig. 6.A). Tumour cells settled down, prolifer-
ated, and gradually populated the device, to possibly replace 
healthy basal cells and eventually affect the overall secretory 
profile of the tissue. Fig. 6.B-D illustrates the 2D peak distribu-
tion of MALDI profiling of supernatants from PNT2, LNCaP 
and PNT2 loaded with 1,000, 10,000 or 50,000 LNCaP cells. 
While LNCaP culture is clearly separated, the differentiation of 
PNT2 and PNT2 co-cultured with LNCaP cells is less obvious. 
However, there is a tendency to separate the PNT2 co-culture 
A.
B. C.
Figure 4. Hemisphere-shaped PE scaffolds. A. RWPE-1 cells cultured for 5 days on a PE coated mould. A deep color elaboration of 
the 3D acquisition shows the cellular distribution on the coated hemisphere (Red 0 μm- blue 50 μm). B. Calibration curve to deter-
mine the volume of secretion. C. Elispot detection of secretions from WPE1-int cells w/o DHT (a); WPE1-int w/DHT (b); RPTEC cells 
(negative control) (c) and 3 ng pure PSA (positive control) (d).
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condition when the amount of LNCaP is increased to 50,000 
cells (Fig. 6.B) 
Integration of self-supporting acinar-like scaffolds within 
Prostate-on-Chip
On the basis of the results obtained with PE-coated hemi-
spheres, we developed incremental systems to construct 
self-supporting finger-like scaffolds providing an access to 
both side of the acinus, basal and luminal. Alginate flowing 
was used to create a sacrificial 3D shaped structure in top of 
which polyelectrolyte membrane would be created. The idea 
was then to obtain a homogeneous region containing several 
alginate pillars. Moreover, the use of a programmable software 
controlled syringe pump would allow a fine optimisation and 
automatisation of the process. Nevertheless, alginate flowing 
through the 3D printed UroSCAF pieces resulted in irregular 
and non-uniform extrusions of alginate from the holes; some-
times extrusions appeared from only one hole. Moreover, when 
the procedure was repeated with the same piece, alginate came 
out from a different hole. These results may have been due to 
microfluidic physical flow-resistance issues, which might be 
due to slight differences in the shape between different holes in 
the same piece that was 3D-printed. 
As this first device (see Fig. 2) didn’t allow the assembly of an 
array of hollow scaffolds in a reproducible manner, we then de-
veloped another approach by assembling 3D-printed modules 
composed of “finger-like” structures instead of microholes (see 
Fig. 3). Alginate gelation was achieved by following a published 
protocol (19) that was adapted to our system. The optimisation 
of the protocol worked out well and the gelation and shaping 
of the alginate was reproducible (data not shown). Thus, polye-
lectrolyte membranes were obtained from alginate moulds con-
A. B.
C.
Figure 5. MALDI profiling statistical analysis of 3 cell lines supernatant. A. Principal Component Analysis of PC3, LNCaP and PNT2 
spectra. B. Unsupervised hierarchical clustering of PC3, LNCaP and PNT2 spectra. Peaks used for 2D peak distribution are highlight-
ed in orange. C. 2D peak distribution, plotting the intensities of peaks 2425 Da and 2482 Da across PC3, LNCaP and PNT2 spectra. 
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taining wells. The dissolution of PE coated alginate moulds by in-
troduction in an EDTA bath resulted in a visible fragile floating 
membrane shaped to the desired structure (Fig. SI.4.A) How-
ever, these floating structures could not be manipulated and the 
protocol was then adapted to provide a membrane that could be 
attached to a glass surface, which would enable the manipulation 
of the obtained polyelectrolyte membrane and its optimisation 
on both the holographic and confocal microscopes. However, 
this procedure induced folding in the polyelectrolyte membrane 
originated by an uneven attachment of the membrane to the bot-
tom of the petri dish. Nevertheless, as expected, this procedure 
allowed us a good optimisation of the shape. The optimisation 
of those membranes showed a difficulty of the finger-like shape 
to remain self-supporting (Fig. SI.4.B) although they seemed to 
hold their shape in the floating membranes. Moreover, when the 
polyelectrolyte membrane was attached to a surface, most of the 
fingers seemed to have exploded or collapsed and were princi-
pally found in three conformations: volcano like, side collapsed 
or central collapsed. We hypothesise that this could be due either 
to the strong electrostatic force created between the glass (coated 
or not) and the polyelectrolyte membrane; or to the electrostatic 
forces produced between the walls of the finger itself.
New UroBOXES pieces were then carefully designed (see Fig. 
3) and created to have a polyelectrolyte membrane accessible 
from both sides and easily manipulated. Promising results were 
obtained from the first trials where almost closed fingers could 
be seen (Fig. SI.4.C). Further optimisations of the protocol re-
sulted in the reduction of the hole size found in the polyelectro-
lyte membrane although the presence of those defects were not 
eliminated. Several hypotheses were then set for the existence 
of this holes which could either be due to: (i) the difficulty to 
remove completely the liquid from the holes due to their small 
size or (ii) the lack of mixing inside each one of the wells due to 
their size. 
Discussion 
In this study we demonstrate how to discriminate non-can-
cerous from cancerous cell lines by MALDI profiling of secre-
tions following 48h of cell growth, with no concentration or 
purification steps and without any a priori on the knowledge 
of targeted proteins. The analysis of the crude supernatants of 3 
different cell lines (PNT2, PC3 and LNCaP) demonstrated the 
capacity of the MALDI MS profiling approach to identify spe-
cific MS signatures. This result encouraged us to further per-
A. B.
D.C.
Figure 6. PNT2 cells co-cultured with LNCaP cells. A. Mixed population of non-cancerous (PNT2) and cancerous (LNCaP) prostatic 
cells. Confocal image of LNCaP labelled with CellTracker™_Green (here in red) on a PNT2 cells layer (here in green) cultured for 72h. 
Blue: Hoechst; Green Phalloidin; Red: LNCaP labelled with CellTracker™_Green. False colors are used for better visibility. Bar : 100 
µm. B. 2D peak distribution of MALDI profiling analysis of PNT2 cells co-cultured with LNCaP cells.
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form the analysis of supernatant samples from PNT2 normal 
cells co-cultured with small amount of LNCaP tumor cells to 
detect a specific MS signature of a tumor invasion mimicking 
condition. As expected, the discriminative ability of MALDI 
profiling was less significant in our experimental settings. How-
ever, the data obtained in the condition with PNT2 co-cultured 
with 50,000 LNCaP cells remain promising. Considering the 
low concentration of cells secretome in the supernatant and the 
presence of highly abundant BSA in the culture media, several 
optimisation steps could be implemented to improve MALDI 
MS detection of pertinent markers. We envision that future 
developments including pre-concentration and enrichment of 
cells secretome in specific microfluidic devices will greatly en-
hance the MALDI detection of specific secreted markers.
It is known that tumour cells change their genetic expres-
sion pattern during the stages of increasing malignancy (19).
That leads to differential secretion of peptides or proteins from 
the tumour cells but only in very low amounts. Existing mass 
spectrometry analysis is variable due to the need to measure 
these small amounts of secreted peptides and proteins in whole 
body fluids. Nonetheless, the principle of the change in levels of 
secreted peptides and proteins has been demonstrated by mea-
suring the supernatant of cultured carcinoma cells using mass 
spectrometry (19). Those published reports from cell culture 
supernatant augurs well for the approach taken by UroLOC, 
since the perspective of UroLOC device is to collect the in-line 
secretions of tumour cells, in a controlled microenvironment, 
for analysis of the secreted peptides and proteins using mass 
spectrometry. In our approach, the status of cancerous cells is 
determined by comparing the analysis of secretions from a pre-
formed layer of normal urothelial cells (“before”) to the change 
in secretions induced after “seeding” the urothelial cells into the 
pre-formed layer (“after”). Thus, unlike previous reported sys-
tems where the markers in secreted fluids are detected by fixed-
cell immunostaining, thus implying the death of the cells (5), 
our UroLOC lab-on-chip device makes it possible to analyse 
in real-time the composition of the secretions from the living 
cells. (For example, the analysis of secreted fluid can be made 
over several days for carrying out kinetic studies, while main-
taining the viability and the functionality of cells over time). As 
a first example to mimic an exocrine gland to demonstrate the 
function our new approach to a 3D lab-on-chip device, we have 
taken the medical problem of measuring changes in the secre-
tions from the acinar cells of the prostate gland and then to 
consider the use of detecting these small changes in secretions 
as an early indicator/diagnostic for prostate cancer.
We also demonstrated in this study the feasibility of 3D shap-
ing a polyelectrolyte membrane resulting in a 3D self-support-
ing nanostructured membrane. At this stage, the polyelectro-
lyte membrane was floating and its manipulation was difficult 
and the realisation of closed finger-like structure in all the holes 
of the pieces still need optimisation for complete reproducibil-
ity. However, our design along with first validation are prom-
ising in the way to closely mimic the functional conditions of 
the secretory ductal/acinar structures. Continuing this devel-
opmental path provides a significant advantage, since it is well-
known that the function of secretory cells changes dramatically 
from the classical 2D culture plates to even Matrigel® cultures. 
Indeed, 3D cultures are essential for investigating more natural 
responses from exocrine tissue such as breast epithelial cells.
Tumour cells change their genetic expression pattern as they 
progress to states of increasing malignancy (19). Investigations 
at the DNA and RNA level alone cannot provide all the infor-
mation resulting after the translation and processing of the 
corresponding proteins, which is one reason for a poor cor-
relation between mRNA and the respective protein abundance. 
In diagnostics, differentially expressed peptides or proteins are 
important markers for the early detection of cancer. Unfortu-
nately, tumour cells secrete peptides and proteins in only very 
low amounts, making mass spectrometric determination very 
difficult. As reported by Peter et al (19), methods have been 
developed for the effective enrichment and cleanup of sub-
stances secreted by cultivated cancer cells. To obviate peptides 
from fetal calf serum used in cell culture, a serum surrogate 
was developed, which maintained growth of the cancer cells. 
After the binding of substances from cell-culture supernatants 
to custom-made magnetic reversed-phase particles, the sub-
stances were eluted and separated by capillary high-perfor-
mance liquid chromatography. Fractions were spotted directly 
on a MALDI target, and MALDI-TOF mass spectrometric data 
acquisition was performed in automatic mode. This technol-
ogy was used to detect substances secreted by two mamma-
ry carcinoma cell lines differing in their malignancy (MCF-7, 
MDA-MB231). Unequivocal differences in the peptide secre-
tion patterns were observed. In conclusion, this system allows 
the sensitive investigation of peptides secreted by cancer cells 
in culture and provides a valuable tool for the investigation of 
cancer cells in different states of malignancy (20).
Our concept to collect secretions directly from the urothe-
lial cells (e.g. prostate) is radically different from the attempt 
to purify these secretions from whole urine. The existing use 
of whole urine as the sample from which to detect molecules 
secreted by cancerous urothelial cells is an arduous task for 
several reasons. Tumour cells secrete peptides and proteins in 
only very low amounts (19). Urine is variable in volume, pH, 
type of background protein “noise”, and is particularly variable 
depending on the time of day of collection (21). Consequently, 
it is very difficult to purify urine in a reliable way in order to de-
tect the small amount of molecules secreted by urothelial cells. 
To have access to those low amounts of peptides and proteins in 
whole urine, existing procedures require complex enrichment 
and cleanup protocols prior to mass spectrometric analysis of 
whole urine.
Conclusion
In conclusion, our work hence anticipates the use of microfluid-
ics connected to our nanostructured scaffolds to obtain concen-
trated secretions without the need of complex filtration (such 
as would be needed by using whole urine). It opens also new 
opportunities in terms of liquid-biopsy based diagnosis (Fig. 
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SI.7). In the early stages of carcinogenesis, only small numbers 
of cells are being transformed into tumour cells, which are ex-
pected to be associated with “minor” changes in the secretome. 
However, the ability to detect those “minor” changes is critical 
for an early-stage diagnosis. Such a diagnosis is not possible if 
whole-urine is measured directly due to the predominance of 
contaminating molecules. To overcome this drawback, our ap-
proach is promising and should allow to improve sensitivity by 
detecting small numbers of cancerous cells in the urinary tract 
and/or prostate for early-stage carcinogenesis. 
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Figure SI.1. Polyelectrolyte coating over alginate moulds procedure. A 3D shaped alginate mould is coated with PE by submerg-
ing it in alternating solutions PSS / PAH until the desired number of layers is obtained. A washing step with water is done between 
each solution change.
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Figure SI.2. Methodology for the determination of the volume of secretions. A.  Bromophenol blue solution deposited with 
Tween 80 on a PDMS mold (1). The excess of blue was absorbed with paper towels (2) while the blue still present in the wells was 
transferred to Watman paper (3). The paper was placed in an Eppendorf tube. Hydration of Watman paper was performed with 
H20 + Tween 80. Then elution was performed by centrifugation (4-6). B. Adding Tween 80 to bromophenol allowed to optimize the 
coating inside the polymeric scaffolds and hence to increase the transfer efficacy on the absorbent paper.
Figure SI.3. UroLOC design. This figure shows all the different pieces of the UroLOC system separated and assembled together. 
From left to right: UroFLU contains channels enabling fluid flow through the system; UroSCAF is a flat piece containing an array of 
holes that enable alginate shaping into finger-like structures; UroPERF provides a cover to the system in which a glass coverslip can 
be fitted for microscopy and protection of the system. Finally the UroLOC system is formed by the assembly of the three pieces. 
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Figure SI.4. 3D finger-like shaped polyelectrolyte membrane. A. Floating 3D shaped polyelectrolyte membrane. A 3D-shaped is 
obtained from an alginate mould. The PE membrane is coloured with methylene blue to allow its visualization. This image provides 
a close look of the finger-like structure revealing the fragility of both the membrane and the base of the finger structure. The image 
was taken with a digital microscope. B. The image shows a collapsed finger-like structure. Although the desired shape is achieved, 
it is collapsed over itself not being able to hold upright by itself. Image was acquired with a Zeiss confocal microscope (10x). C. 3D 
reconstructed confocal image of PE coating over the surface of the finger-like nanostructure. A broken membrane is observed in 
the centre of the hole (red arrow).
Figure SI.5. Biochemical validation of PSA secretion. A. PSA secretion quantified by ELISA for the LNCaP, PNT2 and PC3 cell-lines 
with and without DHT stimulation. B. ELISPOT of LNCaP supernatant with and without DHT stimulation. (Analyse on the same su-
pernatant of the ELISA analysis). C. Western Blot of LNCaP supernatant and cell lysate with and without DHT stimulation. Different 
concentration of supernatant has been tested. D. Protein array for the detection and comparison of secreted proteases in LNCaP 
(Red), PNT2 (Green) and PC3 (Blue). Only proteins with a great difference are shown here.
195The EuroBiotech Journal
Figure SI.6. MALDI profiling statistical analysis of non-cancerous and cancerous cell lines supernatants. Average MALDI Spectra 
of PC3, LNCaP and PNT2 supernatants presenting the peaks 2425 Da and 2482 Da.
Figure SI.7. Perspective of a diagnostic concept for UroLOC. Exfoliated cells are isolated from the urine using gentle centrifugation 
then spiked into a pre-formed layer of neutral epithelial cells in the UroLOC device.  After one day of cell integration, the secretions 
are collected and analysed by Mass Spectrometry (MS). The MS spectrum are deconvoluted into components and compared to 
the reference spectra for normal tissue (e.g. prostate). The presence of a cancer is determined if there is a difference between the 
measured and the reference spectra (yes/no answer).
